Actively Recruiting
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Led by Walter Reed National Military Medical Center · Updated on 2024-02-23
100
Participants Needed
1
Research Sites
343 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This protocol studies the clinical outcome of patients with active thyroid disease with visually significant signs and symptoms of proptosis, pain, diplopiam lid/orbital edema, or lid/orbital erythema recommended for treatment with teprotumumab infusion (Tepezza®). Patients recommended for treatment will be evaluated by an oculoplastic surgeon (Dr. Eva Chou) and endocrinologist (Dr. Thanh Hoang).
CONDITIONS
Official Title
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Only Department of Defense beneficiaries
- Adults aged 18 years or older
- Adults with proptosis, ocular or orbital pain, double vision, eyelid or orbital swelling, or eyelid or orbital redness associated with autoimmune thyroid disease
You will not qualify if you...
- Patients with compressive optic neuropathy requiring urgent orbital decompression or external beam radiation
- Patients with a history of uncontrolled diabetes mellitus
- Patients with a history or diagnosis of uncontrolled inflammatory bowel disease
- Patients under 18 years old
- Patients who are pregnant or trying to become pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Walter Reed National Military Medical Center
Bethesda, Maryland, United States, 20889
Actively Recruiting
Research Team
T
THANH D HOANG, DO
CONTACT
I
Iris Morris, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here